Mitchell Paul Levesque

59PUBLICATIONS

397CO-AUTHORS

Predictive and prognostic markersInnate immunityGene and molecular therapyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (59)

Sort by Publication Date:

|Jul 13, 2026

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

|May 29, 2026

NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

|May 26, 2026

NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

|Mar 28, 2026

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Feb 25, 2026

Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Dec 12, 2025

Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

Pageof 10

Frequent Collaborators

23 joint publications

Reinhard Dummer

11 joint publications

Phil Fang Cheng

11 joint publications

Patrick Turko

Egle Ramelyte

Julia Martínez Gómez

Christian Beisel

Ramon Staeger

Ruedi Aebersold

Federica Sella

Lars E French

Frequent Collaborators

23 joint publications

Reinhard Dummer

11 joint publications

Phil Fang Cheng

11 joint publications

Patrick Turko

8 joint publications

Egle Ramelyte